Valuation: Boston Scientific Corporation

Market Cap 68.46B 60.08B 55.95B 51.46B 96.47B 6,541B 98.12B 664B 260B 3,244B 257B 251B 11,207B P/E 2026 *
16.5x
P/E 2027 * 16.1x
Enterprise Value 74.84B 65.68B 61.16B 56.25B 105B 7,150B 107B 726B 284B 3,546B 281B 275B 12,251B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.07x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day+1.21%
1 week+6.65%
Current month+7.92%
1 month+4.14%
3 months-21.20%
6 months-50.89%
Current year-51.69%
1 week 42.5
Extreme 42.5
47.16
1 month 42.2
Extreme 42.2
47.16
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Fiscal year

Chief Financial Officer

5,184 0.0004%
28/05/26 Don

Chief Executive Officer

-386,755 0.0261%
20/05/26 Buy

Director

1,770 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+1.21%+6.65%-56.48%-10.89% 68.46B
+3.02%+10.12%+18.86%+2.59% 214B
+1.30%+11.19%-1.92%-23.46% 140B
+1.39%+3.35%-26.75%+10.80% 128B
+0.77%-1.03%+6.61%-0.07% 48.18B
+0.47%+4.31%-25.70%-31.73% 45.56B
+1.92%+5.78%+17.57%+11.50% 39.69B
+3.42%+4.45%+26.97%+34.34% 37.69B
+2.90%+6.72%-23.60%-6.37% 30.14B
+1.85%+0.23%+75.63%+0.28% 29.2B
Average +1.82%+4.32%+1.12%-1.30% 78.09B
Weighted average by Cap. +1.91%+5.19%-1.48%-2.53%

Financials

2026 *2027 *
Net sales 21.56B 18.92B 17.62B 16.21B 30.39B 2,060B 30.91B 209B 81.84B 1,022B 80.96B 79.21B 3,530B 23.29B 20.44B 19.04B 17.51B 32.82B 2,225B 33.39B 226B 88.4B 1,104B 87.45B 85.56B 3,813B
Net income 3.96B 3.48B 3.24B 2.98B 5.58B 378B 5.68B 38.39B 15.03B 188B 14.87B 14.54B 648B 4.12B 3.61B 3.36B 3.09B 5.8B 393B 5.9B 39.91B 15.62B 195B 15.45B 15.12B 674B
Net Debt 6.38B 5.6B 5.21B 4.79B 8.98B 609B 9.14B 61.82B 24.2B 302B 23.94B 23.42B 1,044B 3.17B 2.78B 2.59B 2.38B 4.46B 303B 4.54B 30.71B 12.02B 150B 11.89B 11.64B 519B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
28/07/26 $46.06 +1.21% 26,905,670
27/07/26 $45.51 +2.85% 20,044,682
24/07/26 $44.25 +1.54% 20,689,854
23/07/26 $43.58 +1.42% 16,535,740
22/07/26 $42.97 -0.51% 11,201,174
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
46.06USD
Average target price
72.31USD
Spread / Average Target
+56.99%

Quarterly revenue - Rate of surprise